Jyy Fung
University of Hong Kong
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jyy Fung.
Alimentary Pharmacology & Therapeutics | 2006
M.-F. Yuen; Sidney Tam; Jyy Fung; Danny Ka-Ho Wong; B. C. Y. Wong; Ching-Lung Lai
Safety of traditional Chinese medicine in patients with chronic hepatitis B is unknown.
Alimentary Pharmacology & Therapeutics | 2007
Yuk Kei Yee; Ting-Kin Cheung; Kent-Man Chu; C. K. Chan; Jyy Fung; Pierre Chan; David But; Ivan Fan-Ngai Hung; Aoo Chan; M.-F. Yuen; Axel Hsu; B. C. Y. Wong
Background The efficacy of levofloxacin‐based quadruple therapy in resistant Helicobacter pylori infection is not known.
Journal of Hepatology | 2011
Wkw Seto; Cl Lai; Jyy Fung; John Chi-Hang Yuen; Dkh Wong; M.-F. Yuen
This journal supplement is Abstract Book of the International Liver Congress 2011 by EASL (46th Annual Meeting)
Alimentary Pharmacology & Therapeutics | 2016
Wkw Seto; Jyy Fung; Ks Cheung; Lung-Yi Mak; R. Hui; Kevin Sze-Hang Liu; Ching-Lung Lai; M.-F. Yuen
Factors influencing changes in liver stiffness measurements during long‐term nucleoside analogue therapy for chronic hepatitis B (CHB) have not been thoroughly investigated.
British Journal of Surgery | 2017
Ktp Ng; Ksh Chok; Albert C. Y. Chan; Tt Cheung; Tiffany Cho Lam Wong; Jyy Fung; John Chi-Hang Yuen; Rtp Poon; St Fan; Cm Lo
Hepatic resection and radiofrequency ablation (RFA) are treatment options for early‐stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long‐term survival favour either treatment has not been established. This randomized trial aimed to test the hypothesis that RFA is superior to hepatic resection in terms of lower tumour recurrence rate and better long‐term survival.
Alimentary Pharmacology & Therapeutics | 2017
Wkw Seto; Eric H. Y. Lau; J.T. Wu; Ivan Fan-Ngai Hung; Wai K. Leung; Ks Cheung; Jyy Fung; Ching-Lung Lai; M.-F. Yuen
The temporal relationship between nucleoside analogue therapy for chronic hepatitis B (CHB) and liver cancer development has not been evaluated at a population level.
Clinical Microbiology and Infection | 2016
Danny Ka-Ho Wong; Jyy Fung; Cheuk-Kwong Lee; Wkw Seto; J. N. S. Leung; Fung-Yu Huang; Che-Kit Lin; Ching-Lung Lai; M.-F. Yuen
We studied the intrahepatic hepatitis B virus (HBV) replicative status in 40 people with occult hepatitis B infection (OBI) and 40 patients with chronic hepatitis B (CHB). Intrahepatic HBV DNA, covalently closed circular DNA (cccDNA), and pre-genomic RNA (pgRNA) were quantified. Patients with OBI had median necroinflammation and fibrosis scores of 1 and 0, respectively. Intrahepatic total HBV DNA, cccDNA and pgRNA were detectable in 30 (77%), one (3%) and five (13%) of the participants with OBI, respectively. People with OBI had lower median intrahepatic total HBV DNA than the patients with CHB (p < 0.0001). They had nearly normal liver histology and low intrahepatic HBV replication.
Archive | 2012
Wkw Seto; Dkh Wong; Jyy Fung; Ppc Ip; Jch Yuen; Ifn Hung; Cl Lai; Rmf Yuen
The 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012—Taipei, Taiwan—16–19 February
Archive | 2014
Dkh Wong; Jyy Fung; Ck Lee; Wkw Seto; J Leung; Dkh Huang; Ck Lin; Cl Lai; Rmf Yuen
23rd Annual Conference of APASL March 12–15, 2014, Brisbane, Australia Asian Pacific Association for the Study of the Liver 2014 Topic: 1 Acute Liver Failure
Archive | 2011
Wkw Seto; Cl Lai; Jyy Fung; Jch Yuen; Dkh Wong; M.-F. Yuen
The 21st Conference of the Asian Pacific Association for the Study of the Liver
